fda tirzepatide obesity grants fast track designation to tirzepatide, Eli Lilly's new type 2 diabetes drug, for treating Lilly announces more next-gen obesity

Thyroid C-Cell Tumors Studies in rodents have shown a potential risk for thyroid C-cell tumors with tirzepatide

While long-term studies in children are ongoing, 2026 clinical data shows promising results for safely managing adolescent obesity

Reviews of Medicube AGE-R Glutathione Glow Serum Users worldwide praise this serum for its visible glow enhancement and lightweight texture

Corrective Treatments B12/MIC Injections Frequently Asked Questions What are B12/MIC Injections and how do they work

The inhibition of SIRT1 can increase the acetylation level of retinoblastoma protein (Rb) in Pkd1-deficient MEK cells while decreasing its phosphorylation level, releasing E2F transcription factor 1 (E2F1) from the RB-E2F complex, regulating the proliferation signal of renal cystic epithelial cells, and delaying the growth of cysts in ADPKD patients, thereby increasing the apoptosis of cystic epithelial cells (Zhou et al., 2013)

Noale M, Veronese N, Cavallo Perin P, et al